Literature DB >> 17667798

Reference values for hair cotinine as a biomarker of active and passive smoking in women of reproductive age, pregnant women, children, and neonates: systematic review and meta-analysis.

Ana Florescu1, Roberta Ferrence, Thomas R Einarson, Peter Selby, Michael Kramer, Susan Woodruff, Lindsey Grossman, Allison Rankin, Evelyn Jacqz-Aigrain, Gideon Koren.   

Abstract

Exposure to environmental tobacco smoke (ETS) is most often estimated using questionnaires, but they are unreliable. Biomarkers can provide valid information on ETS exposure, the preferred biomarker being cotinine. However, no reference range of hair cotinine exists to distinguish among active, passive, and unexposed nonsmokers. This study identifies cutoffs to validate cotinine as a marker for exposure to ETS. Data were obtained from six databases (four US, one Canada, one France). Active smoking and exposure to ETS were measured in the hair of women of reproductive age, pregnant women, their children, and neonates. Subjects were classified into active smokers, passively exposed to ETS, and unexposed nonsmokers. A total of 1746 cases were available for analysis. For active smokers, mean hair cotinine concentrations (95% confidence interval) were 2.3 to 3.1 ng/mg for nonpregnant women and 1.5 to 1.9 ng/mg for pregnant women. In the group of passive smokers, mean hair cotinine concentrations were 0.5 to 0.7 ng/mg for nonpregnant women, 0.04 to 0.09 ng/mg for pregnant women, 0.9 to 1.1 for children, and 1.2 to 1.7 for neonates. Among unexposed nonsmokers, mean hair cotinine was 0.2 to 0.4 ng/mg in nonpregnant women, 0.06 to 0.09 ng/mg in pregnant women, and 0.3 to 0.4 ng/mg in children. Cutoff values for hair cotinine were established to distinguish active smokers from passive or unexposed (0.8 ng/mg for nonpregnant women and 0.2 ng/mg for pregnant women). A cutoff value of 0.2 ng/mg was accurate in discriminating between exposed children and unexposed. These new values should facilitate clinical diagnosis of active and passive exposure to tobacco smoke. Such diagnosis is critical in pregnancy and in a large number of tobacco-induced medical conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17667798     DOI: 10.1097/FTD.0b013e318074df6e

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  20 in total

1.  Prenatal hair nicotine analysis in homes with multiple smokers.

Authors:  Kristin Ashford; Susan Westneat
Journal:  Nurs Clin North Am       Date:  2011-12-29       Impact factor: 1.208

2.  Environmental tobacco smoke exposure among smokers and non-smokers receiving outpatient substance abuse treatment.

Authors:  Shauna P Acquavita; Erin A McClure; Daniel Hargraves; Maxine Stitzer
Journal:  Addict Behav       Date:  2014-07-17       Impact factor: 3.913

Review 3.  Clinical interventions to reduce secondhand smoke exposure among pregnant women: a systematic review.

Authors:  Van T Tong; Patricia M Dietz; Italia V Rolle; Sara M Kennedy; William Thomas; Lucinda J England
Journal:  Tob Control       Date:  2014-04-30       Impact factor: 7.552

Review 4.  Nicotine chemistry, metabolism, kinetics and biomarkers.

Authors:  Neal L Benowitz; Janne Hukkanen; Peyton Jacob
Journal:  Handb Exp Pharmacol       Date:  2009

Review 5.  Recent contributions of air- and biomarkers to the control of secondhand smoke (SHS): a review.

Authors:  Jacques J Prignot
Journal:  Int J Environ Res Public Health       Date:  2011-03-01       Impact factor: 3.390

6.  Levels of cotinine in dried blood specimens from newborns as a biomarker of maternal smoking close to the time of delivery.

Authors:  Juan Yang; Michelle Pearl; Peyton Jacob; Gerald N DeLorenze; Neal L Benowitz; Lisa Yu; Christopher Havel; Martin Kharrazi
Journal:  Am J Epidemiol       Date:  2013-09-25       Impact factor: 4.897

Review 7.  Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology.

Authors:  Ana Florescu; Roberta Ferrence; Tom Einarson; Peter Selby; Offie Soldin; Gideon Koren
Journal:  Ther Drug Monit       Date:  2009-02       Impact factor: 3.681

8.  Measuring prenatal secondhand smoke exposure in mother-baby couplets.

Authors:  Kristin B Ashford; Ellen Hahn; Lynne Hall; Mary K Rayens; Melody Noland; Rebecca Collins
Journal:  Nicotine Tob Res       Date:  2009-12-27       Impact factor: 4.244

Review 9.  Assessing secondhand smoke using biological markers.

Authors:  Erika Avila-Tang; Wael K Al-Delaimy; David L Ashley; Neal Benowitz; John T Bernert; Sungroul Kim; Jonathan M Samet; Stephen S Hecht
Journal:  Tob Control       Date:  2012-09-02       Impact factor: 7.552

10.  An RCT protocol of varying financial incentive amounts for smoking cessation among pregnant women.

Authors:  Marita Lynagh; Billie Bonevski; Rob Sanson-Fisher; Ian Symonds; Anthony Scott; Alix Hall; Christopher Oldmeadow
Journal:  BMC Public Health       Date:  2012-11-27       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.